Published in Clin Exp Allergy on July 01, 2004
Increased level of basophil CD203c expression predicts severe chronic urticaria. J Korean Med Sci (2013) 0.84
Polymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticaria/angioedema. J Korean Med Sci (2005) 0.81
Chronic urticaria: Indian context-challenges and treatment options. Dermatol Res Pract (2013) 0.77
Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. A.P. Kaplan. Clin Exp Allergy (2004) 0.75
The Results of Autologous Skin Test in Patients with Chronic Urticaria in Hamadan, Iran. Electron Physician (2016) 0.75
Autologous Serum and Plasma Skin Tests in Chronic Spontaneous Urticaria: A Reappraisal. Indian Dermatol Online J (2017) 0.75
Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. M. Ferrer. Clin Exp Allergy (2004) 0.75
The relation of autologous serum and plasma skin test results with urticarial activity score, sex and age in patients with chronic urticaria. Postepy Dermatol Alergol (2015) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Human basophil degranulation triggered by very dilute antiserum against IgE. Nature (1988) 4.00
Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy (1998) 3.20
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72
Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy (2010) 1.67
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy (2008) 1.66
Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol (2014) 1.60
Insulin allergy: clinical manifestations and management strategies. Allergy (2008) 1.56
C3a and C5a stimulate chemotaxis of human mast cells. Blood (1997) 1.55
How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55
Helicobacter pylori infection: a simplified diagnostic approach. Am J Gastroenterol (1990) 1.52
Mast cells. Int J Dermatol (1995) 1.52
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51
Autologous serum skin test reactivity in patients with non-allergic asthma. Clin Exp Allergy (2005) 1.50
Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy (2009) 1.49
Allergen extract-induced interleukin-10 in human memory B cells inhibits immunoglobulin E production. Clin Exp Allergy (2009) 1.47
Risk of second cancers in Waldenström macroglobulinemia. Ann Oncol (2011) 1.47
Hypersensitivity to lipid transfer protein is frequently associated with chronic urticaria. Eur Ann Allergy Clin Immunol (2011) 1.46
Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy (2004) 1.45
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation. Leukemia (2002) 1.45
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
Chronic idiopathic urticaria: what is the meaning of skin reactivity to autologous serum? J Eur Acad Dermatol Venereol (2007) 1.40
HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ (2010) 1.38
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Allergic rhinitis management pocket reference 2008. Allergy (2008) 1.23
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy (2007) 1.16
Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition? Clin Exp Allergy (2006) 1.12
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy (2013) 1.09
Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy (2009) 1.08
Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test. J Eur Acad Dermatol Venereol (2010) 1.08
Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy (2007) 1.07
The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy (2009) 1.07
[Severe hypokalemic episode induced by abuse of fluoro-prednisolone acetate administered nasally and the simultaneous oral consumption of indapamide]. Clin Ter (1985) 1.06
Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients. Br J Dermatol (2008) 1.06
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy (2008) 1.05
Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy (2008) 1.04
GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy (2009) 1.03
Profilin sensitization detected in the office by skin prick test: a study of prevalence and clinical relevance of profilin as a plant food allergen. Clin Exp Allergy (2008) 1.01
Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol (2010) 1.01
Ragweed sensitization in Europe - GA(2)LEN study suggests increasing prevalence. Allergy (2009) 0.99
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study. Allergy (2009) 0.99
Disseminated Geotrichum capitatum infection with predominant liver involvement in a patient with non Hodgkin's lymphoma. Haematologica (1996) 0.99
Personalized pollen-related symptom-forecast information services for allergic rhinitis patients in Europe. Allergy (2013) 0.98
Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy (1987) 0.98
Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy (2001) 0.98
Chronic systemic capillary leak syndrome. Report of a case and review of the literature. J Intern Med (2000) 0.98
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Allergy (2009) 0.98
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy (2008) 0.97
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. Allergy (2010) 0.97
Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol (2007) 0.97
Mediator release after endobronchial antigen challenge in patients with respiratory allergy. J Allergy Clin Immunol (1990) 0.97
Lectin binding sites in duodeno-jejunal mucosae from coeliac children. Histochemistry (1988) 0.96
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy (2007) 0.96
Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol (1998) 0.96
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia. Am J Hematol (1998) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology (2006) 0.95
Idiopathic pulmonary hemosiderosis in an adult. Favourable response to azathioprine. Monaldi Arch Chest Dis (2001) 0.95
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. Allergy (2008) 0.95
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy (2011) 0.95
Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol (2001) 0.95
The relation between paracetamol use and asthma: a GA2LEN European case-control study. Eur Respir J (2008) 0.94
EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study. Clin Exp Allergy (2009) 0.94
Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology (1996) 0.93
Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy (2012) 0.93
Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol (2008) 0.92
RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner. Oncogene (2009) 0.92
A combination of wheat flour, ethanol and food additives inducing FDEIA. Allergy (2002) 0.92
Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol (2012) 0.92
Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol (1999) 0.91
Coagulation activation in autoimmune bullous diseases. Clin Exp Immunol (2009) 0.91
Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy (2008) 0.91
Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clin Exp Dermatol (2007) 0.91
The insulin analog aspart: a safe alternative in insulin allergy. Diabetes Care (2001) 0.91
Functional characterization of specific IgE antibodies for tetanus toxoid. Ric Clin Lab (1983) 0.91
Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin Exp Dermatol (2009) 0.90
Allergic rhinitis: prevalence and possible risk factors in a Gulf Arab population. Allergy (2009) 0.90
Reliability and usefulness of random fecal alpha 1-antitrypsin concentration: further simplification of the method. J Pediatr Gastroenterol Nutr (1985) 0.90
Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol (2009) 0.89
Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy (2008) 0.89
Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy (2009) 0.89
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol (2001) 0.88
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy (2011) 0.88
Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol (2011) 0.88
Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria. Allergy (2009) 0.88
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy (2009) 0.88
Analysis of hypersensitivity to oleaceae pollen in an olive-free and ash-free area by commercial pollen extracts and recombinant allergens. Eur Ann Allergy Clin Immunol (2011) 0.87